{"id":"https://openalex.org/W2410698218","doi":null,"title":"Treatment of metastatic renal cell carcinoma with high-dose bolus interleukin-2 in a non-intensive care unit: an analysis of 124 consecutively treated patients.","display_name":"Treatment of metastatic renal cell carcinoma with high-dose bolus interleukin-2 in a non-intensive care unit: an analysis of 124 consecutively treated patients.","publication_year":2001,"publication_date":"2001-03-01","ids":{"openalex":"https://openalex.org/W2410698218","mag":"2410698218","pmid":"https://pubmed.ncbi.nlm.nih.gov/11324764"},"language":"en","primary_location":{"id":"pmid:11324764","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11324764","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer journal (Sudbury, Mass.)","raw_type":"Clinical Trial"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044795397","display_name":"Barbara Jennifer Gitlitz","orcid":"https://orcid.org/0009-0001-0107-3135","observed_orcids":["https://orcid.org/0009-0001-0107-3135"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I4390039293","display_name":"UCLA Jonsson Comprehensive Cancer Center","ror":"https://ror.org/0599cs764","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I4390039293"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B J Gitlitz","raw_affiliation_strings":["Department of Medicine, University of California at Los Angeles School of Medicine, Jonsson Comprehensive Cancer Center, 90095, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of California at Los Angeles School of Medicine, Jonsson Comprehensive Cancer Center, 90095, USA","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I4390039293"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014710892","display_name":"David Hoffman","orcid":"https://orcid.org/0000-0001-7843-4202","observed_orcids":["https://orcid.org/0000-0001-7843-4202"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D M Hoffman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030332656","display_name":"Nancy P. Moldawer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Moldawer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042294498","display_name":"A Belldegrun","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Belldegrun","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5050649350","display_name":"Robert A. Figlin","orcid":"https://orcid.org/0000-0002-6323-6075","observed_orcids":["https://orcid.org/0000-0002-6323-6075"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R A Figlin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.3435,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.88710086,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"7","issue":"2","first_page":"112","last_page":"20"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-renal-cell-carcinoma","display_name":"metastatic renal cell carcinoma","score":0.9739999771118164},{"id":"https://openalex.org/keywords/high-dose-interleukin-2","display_name":"high-dose interleukin-2","score":0.921999990940094},{"id":"https://openalex.org/keywords/ecog-performance-status","display_name":"ECOG performance status","score":0.8859999775886536},{"id":"https://openalex.org/keywords/symptomatic-patients","display_name":"symptomatic patients","score":0.8240000009536743},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.8109999895095825},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6930000185966492},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.7570000290870667}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9296644330024719},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6683029532432556},{"id":"https://openalex.org/C2777910003","wikidata":"https://www.wikidata.org/wiki/Q1707292","display_name":"Asymptomatic","level":2,"score":0.6551968455314636},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.6059368252754211},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5364186763763428},{"id":"https://openalex.org/C2776376669","wikidata":"https://www.wikidata.org/wiki/Q5094647","display_name":"Intensive care unit","level":2,"score":0.5339459180831909},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.5150589942932129},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.47577229142189026},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4670732319355011},{"id":"https://openalex.org/C2777793932","wikidata":"https://www.wikidata.org/wiki/Q1116229","display_name":"Common Terminology Criteria for Adverse Events","level":3,"score":0.42831677198410034},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.42550593614578247},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4198059141635895},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.34202706813812256},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D003422","descriptor_name":"Critical Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006757","descriptor_name":"Hospital Units","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011859","descriptor_name":"Radiography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:11324764","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11324764","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer journal (Sudbury, Mass.)","raw_type":"Clinical Trial"},{"id":"mag:2410698218","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11324764","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2123914905","https://openalex.org/W2045417020","https://openalex.org/W2590791711","https://openalex.org/W1979932530","https://openalex.org/W2098136315","https://openalex.org/W2138463196","https://openalex.org/W1992350807","https://openalex.org/W2227568616","https://openalex.org/W2072778837","https://openalex.org/W2073352490"],"abstract_inverted_index":{"PURPOSE:":[0],"In":[1,99],"prior":[2],"studies":[3,39],"of":[4,12,19,24,33,45,78,83,103,129,140,146,166,174,183,224,231,246,250,278,287,318],"high-dose":[5,65,104,291],"interleukin-2":[6],"(IL-2)":[7],"therapy":[8,67,87,293],"in":[9,68,90,270,282,298,308],"the":[10,17,61,115,127,214,222,316],"treatment":[11],"metastatic":[13],"renal":[14],"cell":[15],"carcinoma,":[16],"majority":[18,223],"patients":[20,25,108,150,154,168,176,226,234,239,283],"were":[21,109,121,227,242],"asymptomatic":[22,301],"(65%":[23],"had":[26,180],"Eastern":[27],"Cooperative":[28],"Oncology":[29],"Group":[30],"[ECOG]":[31],"scores":[32,182,286],"0":[34,46],"[no":[35],"cancer-related":[36,79],"symptoms]).":[37],"These":[38],"demonstrated":[40],"that":[41,290],"an":[42,48],"ECOG":[43,181,285],"score":[44],"predicted":[47],"objective":[49,141,279],"antitumor":[50,280],"response":[51,62,187],"to":[52,64,212,259],"IL-2":[53,66,86,105,266,292,304],"(P":[54],"=":[55,75],"0.03).":[56],"The":[57,85,138,185,198,248,276],"current":[58],"study":[59,102],"determined":[60],"frequency":[63,139,249,277],"a":[69,91,271,309],"primarily":[70],"symptomatic":[71,299],"patient":[72],"population":[73],"(ECOG":[74],"1":[76,288],"[presence":[77],"symptoms]":[80],"for":[81,192,205,218],"57.3%":[82],"patients).":[84,148],"was":[88,143,209,257,267],"administered":[89,269,307],"non-intensive":[92,272],"care":[93,273],"unit":[94],"(non-ICU).":[95],"PATIENTS":[96],"AND":[97],"METHODS:":[98],"this":[100],"single-institution":[101],"therapy,":[106],"124":[107,147],"consecutively":[110],"enrolled":[111],"and":[112,119,126,132,152,160,172,237,253,265,300,315],"treated":[113],"with":[114,170,178,235,240,284,312],"drug.":[116],"Antitumor":[117],"responses":[118,142,158,162,281],"safety":[120],"assessed":[122],"by":[123],"radiographic":[124],"methods":[125],"occurrence":[128],"grade":[130,251],"3":[131,252],"4":[133,254],"adverse":[134,255],"events,":[135],"respectively.":[136,164],"RESULTS:":[137],"14.5%":[144],"(18":[145],"Seven":[149],"(5.6%)":[151],"11":[153,175],"(8.9%)":[155],"experienced":[156],"complete":[157],"(CRs)":[159],"partial":[161],"(PRs),":[163],"Two":[165],"7":[167,173],"(28.6%)":[169],"CR":[171,236],"(63.6%)":[177],"PR":[179,241],"1.":[184],"median":[186,199,215],"duration":[188,201,217],"is":[189,202],"18":[190],"months":[191,204],"all":[193,206,219],"responders":[194,220],"(CR":[195],"plus":[196],"PR).":[197],"survival":[200,216],"15":[203],"patients.":[207,302],"It":[208],"not":[210],"possible":[211],"estimate":[213],"because":[221],"responding":[225],"alive":[228,243],"at":[229,244],"close":[230,245],"study.":[232,247],"All":[233],"5":[238],"events":[256],"comparable":[258,296],"or":[260],"less":[261],"than":[262],"published":[263],"data":[264],"safely":[268],"unit.":[274],"CONCLUSION:":[275],"suggests":[289],"may":[294],"have":[295],"effectiveness":[297],"High-dose":[303],"can":[305],"be":[306],"non-ICU":[310],"setting":[311],"acceptable":[313],"toxicity":[314],"chance":[317],"clinical":[319],"benefit.":[320]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}